Market Place
Sourcing Support
All News #Library
Biotech
Soligenix Reveals Long-Term Stability of Ebola Protein Vaccines
04 Sep 2025 //
PR NEWSWIRE
Soligenix Extends Filovirus Vaccine Patent Protection to UK, S.Africa
25 Apr 2024 //
PR NEWSWIRE
FDA Grants Soligenix Orphan Status For Sudan Ebolavirus
11 Apr 2024 //
PR NEWSWIRE
FDA Grants Soligenix "Fast Track" Designation for Dusquetide
08 Jan 2024 //
PRESS RELEASE
Soligenix Announces Publication Showing Protection Against Filovirus Disease
02 Jan 2024 //
PR NEWSWIRE
Soligenix Announces Achievement of Two-Year Stability with Bivalent Vaccines
25 Sep 2023 //
PR NEWSWIRE
Soligenix Announces European Patent Grant for Use of Dusquetide Oral Mucositis
16 May 2023 //
PR NEWSWIRE
Soligenix Receives USAN Approval for "Hypericin Sodium" as Nonproprietary Name
05 Apr 2023 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.